{
    "version": "1.0",
    "type": "rich",
    "width": "",
    "height": "",
    "title": "Blir Forxiga det første SGLT2-legemidlet for behandling av pasienter med kronisk nyresykdom?",
    "url": "https://www.healthtalk.no/legemidler-og-biotek/blir-forxiga-det-forste-sglt2-legemidlet-for-behandling-av-pasienter-med-kronisk-nyresykdom/114001",
    "author_name": "healthtalk",
    "author_url": "https://www.healthtalk.no",
    "provider_name": "Labrador",
    "provider_url": "http://www.labradorcms.com/",
    "html": "<div class=\"labrador-cms-embed\" data-lab-style=\" dac-embed-full\" data-lab-content=\"full\" data-lab-id=\"114001\" data-lab-site=\"www.healthtalk.no\"><script async defer src=\"https://www.healthtalk.no/embed.js?v=335\"></script></div>"
}